Theorem Clinical Research Announces Rosenfeld as Vice President of Medical and Scientific Affairs, Medical Device and Diagnostics

Theorem Clinical Research Announces Rosenfeld as Vice President of Medical and Scientific Affairs, Medical Device and Diagnostics

KING OF PRUSSIA, Pa., Mar 20, 2012 (BUSINESS WIRE) -- Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, is pleased to announce the appointment of Evan Rosenfeld, M.D., J.D., F.C.L.M., as vice president of medical and scientific affairs, Medical Device and Diagnostics.

Rosenfeld has more than ten years experience within the medical device and diagnostic industries as both an attorney and medical director.

"Evan has a very dynamic background," stated Theorem Clinical Research Chief Executive Officer John Potthoff. "He initially worked as a lawyer for medical device clients and then moved into chief medical officer roles within these companies after graduating from medical school. Evan understands this industry from both the legal and strategic leadership perspective, and he will be a great asset to our company."

A cum laude graduate of Harvard University, Rosenfeld also graduated cum laude from the University of Pennsylvania Law School. He later obtained his medical degree from the Medical College of Virginia/Virginia Commonwealth University.

Rosenfeld previously served as the medical director and senior consultant for regulatory and clinical affairs at Emergo Group Inc. At the same time, he founded MDJD Consulting and worked as an independent consultant providing medical, clinical and regulatory analysis, insights and strategic recommendations.

Rosenfeld has also worked as the chief medical officer/senior vice president of regulatory affairs at Microtransponder Inc. and as chief medical officer/vice president of medical and regulatory affairs at Bioness Inc.

Currently, he holds active physician licenses with the Texas Medical Board and the Medical Board of California. A fellow of the American College of Legal Medicine, Rosenfeld also holds membership with the Commonwealth of Pennsylvania Bar, the United States Patent and Trademark Office Bar, the District of Columbia Bar and the State of Illinois Bar.

About Theorem Clinical Research Theorem Clinical Research is one of the industry's leading full-service, contract research organizations (CRO). Before launching in 2011, Theorem Clinical Research operated for nearly two decades as Omnicare Clinical Research under the Omnicare Inc. parent company. A global organization with 1,000+ employees located throughout 27 countries, Theorem Clinical Research provides core CRO services for Phases I-IV, but with niche business units in the areas of technical services, medical devices and pharmaceutics with speed, flexibility and attention to detail to drive a high-quality performance. For more information, visit www.theoremclinical.com .

SOURCE: Theorem Clinical Research


       
        Theorem Clinical Research
        Shawn Clary, 484-679-2400
        [email protected]
     

Suggested Articles

Monoclonal antibodies developer Xencor extended a strategic alliance formed in 2016 with Selexis with four commercial license agreements.

Raxone is currently in a phase 3 study on DMD patients who are taking glucocorticoids.

The SuperHuman library contains over 5,000 hits against each of the 26 Distributed Bio targets in immunology and neurodegeneration.